Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Irosustat

Generic Name: Irosustat

Drug Type: Small Molecule

Chemical Formula: C_₁₄H_₁₅NO_₅S

CAS Number: 288628-05-7

Unique Ingredient Identifier: 366037O6O7

Overview

Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.

Background

Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

BN83495 Phase I in Post-menopausal Women

Phase 1

Completed

Posted: 2013/04/25

Sponsor:Ipsen

ID:NCT01840488

A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.

Phase 2

Completed

Posted: 2013/02/07

Sponsor:Imperial College Lon...

ID:NCT01785992

A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth

Phase 2

Terminated

Posted: 2012/08/10

Sponsor:Imperial College Lon...

ID:NCT01662726

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Phase 2

Terminated

Posted: 2010/12/01

Sponsor:Ipsen

ID:NCT01251354

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Phase 2

Terminated

Posted: 2010/10/29

Sponsor:Ipsen

ID:NCT01230970

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy